New Study Analyzes HIV Treatment Funding Needs and Gaps in 97 Countries
December 1, 2015
A modeling study published last week in the journal PLOS Medicine shows that site-level HIV treatment will cost $53 billion in 97 countries worldwide in order to achieve the "90-90-90" treatment targets set by the Joint United Nations Programme on HIV/AIDS. This three-part target, to be met by 2020, aims for 90% of people living with HIV to know their status, 90% of those diagnosed to receive sustained antiretroviral therapy (ART), and 90% of those receiving ART to have viral suppression. Meeting these goals is estimated to require an additional 21 million people to be on ART from 2013 to 2020, but anticipated funding levels will not be able to support this ambitious increase in the availability of and access to ART. UNAIDS estimates that even more resources ($31 billion in 2020) may be needed to achieve broader targets in the UNAIDS 2016-2021 Strategy [1], suggesting that additional resource mobilization and efficiency and effectiveness gains are needed to meet global HIV targets.
The research is the first study to comprehensively project the financial resources needed and available for HIV treatment.
View the article on PLOS Medicine.
[1] UNAIDS. 2015. On the Fast-Track to End AIDS by 2030: Focus on Location and Population. Geneva, Switzerland: UNAIDS.
